---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-039016"
form_type: "8-K"
ticker: "BCTX"
cik: "0001610820"
company_name: "BriaCell Therapeutics Corp."
filed_at: "2024-10-01T23:59:59+00:00"
generated_at: "2026-05-30T23:27:42.729080+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BriaCell: 100% resolution of temporal lobe brain metastasis in heavily pre-treated breast cancer patient

## Summary
- Patient with 'eye-bulging' orbital tumor and brain metastasis achieved complete resolution of temporal lobe lesion at 8 and 11 months on Bria-IMT plus checkpoint inhibitor.
- Heavily pre-treated patient had failed 8 prior regimens including ADC therapy; continues treatment after 17 cycles and 12 months on study.
- Orbital tumor showed near-complete resolution; tumor markers (blood tests) sustained drop confirming imaging results.
- CEO cites unprecedented potential in metastatic breast cancer brain metastasis; Phase 3 study evaluating brain metastasis subgroup ongoing.

## SEC filing metadata
- accession: 0001493152-24-039016
- form_type: 8-K
- ticker: BCTX
- cik: 0001610820
- company_name: BriaCell Therapeutics Corp.
- filed_at: 2024-10-01T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610820/000149315224039016/0001493152-24-039016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610820/000149315224039016/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-039016
- JSON: https://secwatch.observer/filing/0001493152-24-039016.json
- Plain text: https://secwatch.observer/filing/0001493152-24-039016.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.